BPA Call 36C24820A0028-36C24824N0168

Award Date 11/16/23
Potential Completion Date 9/30/24
Potential Value $802K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Emigration Canyon, UT 84108, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing, is for molecular pathogen detection services. The contract, valued at $810,091.80, was awarded by the Veterans Health Administration (VHA) of the Department of Veterans Affairs (VA) under the VA's Veterans Integrated Service Network (VISN) 8. The contract is a BPA (Blanket Purchase Agreement) call against Biofire's General Services Administration (GSA) Federal Supply...
This is a federal contract award to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing. The contract, valued at $116,104.53, was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) for "MOLECULAR PATHOGEN DETECTION" services. It was awarded as a Blanket Purchase Agreement (BPA) call, a type of Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle, against Biofire's existing General...
This federal contract award to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing, is for the provision of molecular pathogen detection services. The contract is a Blanket Purchase Agreement (BPA) call against Biofire's existing General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents and tests. The $430,808.73 ceiling value contract has a firm fixed price pricing type and was awarded by the...
This federal contract award to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing, is for the provision of MOLECULAR PATHOGEN DETECTION services. The $977,947.90 Firm Fixed Price contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) and its various Veterans Integrated Service Networks. The contract is a call against Biofire's General Services Administration (GSA) Federal Supply Schedule contract for...
This is a federal contract award to Biofire Diagnostics LLC, a biotechnology company that specializes in syndromic infectious disease testing. The contract, awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA), is for molecular pathogen detection services. The contract has a ceiling value of $513,156.00 and a period of performance through September 30, 2024. The contract was awarded against Biofire's existing General Services Administration (GSA) Federal...
This is a federal contract award to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing. The award, valued at $1,598,542.00, is for molecular pathogen detection products and services. The contract was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) and its Veterans Integrated Service Network (VISN) 8. The contract is a Blanket Purchase Agreement (BPA) call against Biofire's General Services Administration...
This federal contract award to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing, is for a Blanket Purchase Agreement (BPA) call under their existing General Services Administration (GSA) Federal Supply Schedule 65-VII contract for in vitro diagnostics, reagents, and tests. The contract is with the Veterans Health Administration (VHA) within the Department of Veterans Affairs and has a ceiling value of $171,925.20. It is for the provision of...
This federal contract award to Biofire Diagnostics LLC, a for-profit foreign-owned biotech company, is for "MOLECULAR PATHOGEN DETECTION" services. The contract is a Blanket Purchase Agreement (BPA) Call against Biofire's General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests. The contract has a firm fixed price and a total ceiling value of $1,310,556.75. The award was made by the Department of Veterans Affairs (VA) Veterans...
This is a federal contract award to Biofire Diagnostics LLC, a biotech company that specializes in syndromic infectious disease testing. The contract, valued at $6,877,509.36, is for BIOFIRE TESTING PANELS and was awarded by the Veterans Health Administration (VHA), which is part of the U.S. Department of Veterans Affairs (VA). The contract is a Delivery Order against Biofire's existing General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents, and...
This federal contract award to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing, is for molecular pathogen detection services. The contract is a Blanket Purchase Agreement (BPA) call against Biofire's own General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests. The award, valued at $171,925.20, is for the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to procure...

This federal contract award to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing, is for $801,960.90 to provide "Molecular Pathogen Detection" services. The contract was awarded by the Veterans Health Administration (VHA), part of the Department of Veterans Affairs (VA), and is not set aside.

The contract is a Blanket Purchase Agreement (BPA) call against Biofire's General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests. This establishes a long-term vehicle for VHA to procure Biofire's infectious disease testing products and services on an as-needed basis. The contract has a period of performance through September 30, 2024.

Biofire Diagnostics has held multiple federal contracts and grants with the VHA, Defense Health Agency, Indian Health Service, and Department of State for a range of infectious disease testing capabilities, including COVID-19. This award further demonstrates Biofire's position as a leading provider of molecular diagnostic solutions to key government healthcare agencies.

Generated 7/19/24, 9:02 AM